Vol - 28, Issue - 09
About the Journal
[This article belongs to Volume - 28, Issue - 09]
International Medical Journal
Journal ID : IMJ-18-09-2021-935
Total View : 432

Abstract : The development of HF following an MI is a high-risk occurrence that will negatively impact the patient's long-term outcome. Though timely reperfusion is the most effective treatment to preserve the myocardium, medical therapy has a crucial role in avoiding or even correcting LV failure. In these individuals, newer medical therapies (ARNI and SGLT2i) have a potential role to play. Although initial evidence showed safety to use, reliable data regarding the added benefit is lacking.

Our Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
Certificates
//